中文

美好医疗 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-18

美好医疗 reported revenue of ¥0.81B for the period ended 2026-06-30, +11.0% year on year. Net income was ¥0.12B, a 15.3% net margin on a 40.9% gross margin. The largest revenue line is 医疗产品组件 at 81% of the total. Free cash flow for the period was ¥0.06B.

ItemAmountY/Y
Revenue¥0.81B+11.0%
Gross profit¥0.33B
Operating income¥0.14B
Net income¥0.12B+8.8%
Gross margin40.9%Net margin 15.3%
Revenue Q/Q+1.8%

Revenue Segments

SegmentRevenueShare
医疗产品组件¥0.66B81.0%
健康及食用安全产品组件¥0.11B14.0%
智能装备与技术服务¥0.04B4.5%
其他类¥0.00B0.6%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.48B59.1%
R&D¥0.06B7.7%
SG&A¥0.09B10.9%
Tax & other¥0.02B2.5%

Balance sheet & cash flow

ItemAmount
Total assets¥4.21B
Total liabilities¥0.51B
Shareholders' equity¥3.69B
Equity / assets87.8%
Operating cash flow¥0.09B
Capital expenditure¥0.04B
Free cash flow¥0.06B
Cash conversion (OCF / net income)133%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

矩阵股份一博科技瑞迈特丰立智能联动科技国科恒泰敷尔佳科净源凌玮科技致欧科技鼎泰高科通达海

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies